Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG | Q16739 | 4/20 | 0.44 |
| ▸ | PIK3CD | O00329 | 10/20 | 0.34 |
| ▸ | PIK3R2 | O00459 | 10/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 10/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 10/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 10/20 | 0.34 |
| ▸ | PIK3R5 | Q8WYR1 | 10/20 | 0.34 |
| ▸ | PIK3R3 | Q92569 | 10/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | OXTR | P30559 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16339415 | 1.00 | UGCG (0.44) | UGCGPIK3CDPIK3R2PIK3CAPIK3CB | |
| SCHEMBL16340010 | 0.88 | UGCG (0.30) | UGCG | |
| SCHEMBL16340259 | 0.87 | SCD5 (0.35) | UGCGPIK3CDPIK3R2PIK3CAPIK3CB | |
| SCHEMBL16339523 | 0.86 | ALDH1A1 (0.36) | UGCGPIK3CDPIK3R2PIK3CAPIK3CB | |
| SCHEMBL16377975 | 0.85 | CCNA2 (0.36) | PIK3CDPIK3R2PIK3CAPIK3CBPIK3CG | |
| SCHEMBL16377935 | 0.82 | CCNA2 (0.40) | — | |
| SCHEMBL29670722 | 0.82 | — | — | |
| SCHEMBL17381959 | 0.81 | — | — | |
| SCHEMBL17789666 | 0.81 | PIK3CD (0.33) | UGCGPIK3CDPIK3R2PIK3CAPIK3CB | |
| SCHEMBL30681663 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11365199-B2 | Pyrazole compounds as modulators of FSHR and uses thereof | MERCK PATENT GMBH (DE) | 2022-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11365199-B2 | Pyrazole compounds as modulators of FSHR and uses thereof | FSHR, GNRHR, LHCGR | UGCG 4222/4885PIK3CD 927/4885PIK3R2 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.